AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Brexpiprazole 2 Mg ;

10 registrations across 1 African market— 10 active

Markets with Brexpiprazole 2 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Rexozolex 2 mg
Film Coated Tablets
🇪🇬Egyptal andalous for pharmaceutical industriesactive
Brexpiprazole –clavita pharma 2 mg
Film Coated Tablets
🇪🇬EgyptCLAVITA PHARMAactive
Zetazolex 2mg
Film Coated Tablets
🇪🇬EgyptZeta Pharma for Pharmaceutical Industries (Zeta Pharma)active
Neopression 2mg
Film Coated Tablets
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
Brexopaon
Film Coated Tablets
🇪🇬EgyptOctober Pharmaactive
Brexopaon
Film Coated Tablets
🇪🇬EgyptOctober Pharmaactive
Brexpiprazole –clavita pharma 2 mg
Film Coated Tablets
🇪🇬EgyptCLAVITA PHARMAactive
Rexozolex 2 mg
Film Coated Tablets
🇪🇬Egyptal andalous for pharmaceutical industriesactive
Zetazolex 2mg
Film Coated Tablets
🇪🇬EgyptZeta Pharma for Pharmaceutical Industries (Zeta Pharma)active
Neopression 2mg
Film Coated Tablets
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive

Brexpiprazole 2 Mg ; in Africa — Regulatory Overview

Brexpiprazole 2 Mg ; is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.